Hims & Hers shares surge 50% after Novo Nordisk drops patent infringement case over compounded weight loss drugs
--------------------------------------------------------------------
Source: CNBC
Published: 2026-03-09 23:32 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Law & Courts, Drugs, Business & Economy
--------------------------------------------------------------------
Snippet:
Novo Nordisk has dropped its legal case against telehealth provider Hims & Hers over patent infringement, after the two companies agreed Hims would sell Novo's branded medicines through its platform.
--------------------------------------------------------------------